Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹8,365 Cr
up ₹467 Cr vs Mar 2026
- Stocks held
- 34
- down 1 vs Mar 2026
- Top 10 weight
- 59.5%
- of the portfolio in its ten largest
- Cash & debt
- 1.3%
- cash, money market and debt
- Moves this month
- 0 in · 1 out
- added to 10, trimmed 2
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In April 2026 it disclosed 34 stocks worth ₹8,365 Cr, up ₹467 Cr from Mar 2026. Its largest positions were Sun Pharmaceutical Industries Limited (13.8%), Lupin Limited (7.9%), Dr. Reddy's Laboratories Limited (7.0%); the ten largest together made up 59.5% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 74.1% of its equity. Cash and debt stood at 1.3%. Compared with Mar 2026 the fund entered 0 new stocks and exited 1.
Against 226 other Sectoral / Thematic funds
Concentration
83%
Top-10 weight is higher than 83% of peers
Breadth
21%
Holds more stocks than 21% of peers
Cash
17%
Holds more cash than 17% of peers
Holdings in April 2026
Download CSVEvery line the fund disclosed, with the change against Mar 2026. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 13.85%
- Δ weight
- down 0.07 pts
- Value
- ₹1,158 Cr
- Δ value
- up ₹59.1 Cr
- Status
- Added
- Weight
- 7.95%
- Δ weight
- down 0.50 pts
- Value
- ₹665 Cr
- Δ value
- down ₹2.5 Cr
- Status
- Held
- Weight
- 7.04%
- Δ weight
- up 1.08 pts
- Value
- ₹589 Cr
- Δ value
- up ₹118 Cr
- Status
- Added
- Weight
- 6.61%
- Δ weight
- up 0.21 pts
- Value
- ₹553 Cr
- Δ value
- up ₹47.3 Cr
- Status
- Added
- Weight
- 5.47%
- Δ weight
- up 0.05 pts
- Value
- ₹458 Cr
- Δ value
- up ₹29.8 Cr
- Status
- Added
- Weight
- 5.01%
- Δ weight
- down 0.15 pts
- Value
- ₹419 Cr
- Δ value
- up ₹11.9 Cr
- Status
- Added
- Weight
- 3.78%
- Δ weight
- down 0.08 pts
- Value
- ₹316 Cr
- Δ value
- up ₹11.7 Cr
- Status
- Added
- Weight
- 3.36%
- Δ weight
- up 0.21 pts
- Value
- ₹281 Cr
- Δ value
- up ₹32.2 Cr
- Status
- Added
- Weight
- 3.27%
- Δ weight
- up 0.12 pts
- Value
- ₹273 Cr
- Δ value
- up ₹24.9 Cr
- Status
- Added
- Weight
- 3.19%
- Δ weight
- down 0.17 pts
- Value
- ₹267 Cr
- Δ value
- up ₹1.7 Cr
- Status
- Added
- Weight
- 3.16%
- Δ weight
- down 0.08 pts
- Value
- ₹264 Cr
- Δ value
- up ₹8.2 Cr
- Status
- Added
- Weight
- 3.04%
- Δ weight
- up 0.17 pts
- Value
- ₹254 Cr
- Δ value
- up ₹27.3 Cr
- Status
- Added
- Weight
- 2.83%
- Δ weight
- up 0.02 pts
- Value
- ₹237 Cr
- Δ value
- up ₹14.5 Cr
- Status
- Added
- Weight
- 2.55%
- Δ weight
- down 0.09 pts
- Value
- ₹213 Cr
- Δ value
- up ₹4.9 Cr
- Status
- Added
- Weight
- 2.50%
- Δ weight
- down 0.27 pts
- Value
- ₹209 Cr
- Δ value
- down ₹9.6 Cr
- Status
- Trimmed
- Weight
- 2.26%
- Δ weight
- down 0.18 pts
- Value
- ₹189 Cr
- Δ value
- down ₹3.6 Cr
- Status
- Trimmed
- Weight
- 2.11%
- Δ weight
- up 0.16 pts
- Value
- ₹176 Cr
- Δ value
- up ₹22.6 Cr
- Status
- Added
- Weight
- 2.09%
- Δ weight
- down 0.08 pts
- Value
- ₹175 Cr
- Δ value
- up ₹3.3 Cr
- Status
- Added
- Weight
- 1.99%
- Δ weight
- down 0.03 pts
- Value
- ₹167 Cr
- Δ value
- up ₹6.7 Cr
- Status
- Added
- Weight
- 1.79%
- Δ weight
- down 0.11 pts
- Value
- ₹150 Cr
- Δ value
- down ₹31 L
- Status
- Held
- Weight
- 1.74%
- Δ weight
- up 0.07 pts
- Value
- ₹146 Cr
- Δ value
- up ₹13.3 Cr
- Status
- Added
- Weight
- 1.68%
- Δ weight
- down 0.04 pts
- Value
- ₹140 Cr
- Δ value
- up ₹4.4 Cr
- Status
- Added
- Weight
- 1.50%
- Δ weight
- down 0.01 pts
- Value
- ₹125 Cr
- Δ value
- up ₹6.3 Cr
- Status
- Added
- Weight
- 1.43%
- Δ weight
- up 0.50 pts
- Value
- ₹120 Cr
- Δ value
- up ₹46.3 Cr
- Status
- Added
- Weight
- 1.32%
- Δ weight
- up 0.20 pts
- Value
- ₹111 Cr
- Δ value
- up ₹21.8 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 1.32%
- Δ weight
- up 0.78 pts
- Value
- ₹110 Cr
- Δ value
- up ₹67.7 Cr
- Status
- Added
- Weight
- 1.22%
- Δ weight
- up 0.11 pts
- Value
- ₹102 Cr
- Δ value
- up ₹14.1 Cr
- Status
- Added
- Weight
- 1.22%
- Δ weight
- up 0.05 pts
- Value
- ₹102 Cr
- Δ value
- up ₹10 Cr
- Status
- Added
- Weight
- 0.99%
- Δ weight
- up 0.10 pts
- Value
- ₹82.9 Cr
- Δ value
- up ₹12.3 Cr
- Status
- Added
- Weight
- 0.96%
- Δ weight
- up 0.08 pts
- Value
- ₹80.5 Cr
- Δ value
- up ₹11 Cr
- Status
- Added
- Weight
- 0.94%
- Δ weight
- up <0.01 pts
- Value
- ₹78.5 Cr
- Δ value
- up ₹4.5 Cr
- Status
- Added
- Weight
- 0.63%
- Δ weight
- down 0.04 pts
- Value
- ₹52.8 Cr
- Δ value
- down ₹18 L
- Status
- Held
- Weight
- 0.61%
- Δ weight
- down <0.01 pts
- Value
- ₹51.4 Cr
- Δ value
- up ₹2.8 Cr
- Status
- Added
- Weight
- 0.46%
- Δ weight
- up 0.08 pts
- Value
- ₹38.4 Cr
- Δ value
- up ₹8.3 Cr
- Status
- Added
- Weight
- 0.15%
- Δ weight
- up 0.01 pts
- Value
- ₹12.8 Cr
- Δ value
- up ₹1.4 Cr
- Status
- Added
What changed, Mar 2026 to Apr 2026
New New positions (0)
None.
Exited Exited (1)
- JB Chemicals & Pharmaceuticals Limitedwas 2.1% · ₹165 Cr
Added Biggest additions
- Dr. Reddy's Laboratories Limitedup ₹118 Cr (+1.08% pts)
- Sun Pharmaceutical Industries Limitedup ₹59.1 Cr (−0.07% pts)
- Divi's Laboratories Limitedup ₹47.3 Cr (+0.21% pts)
- Syngene International Limitedup ₹46.3 Cr (+0.50% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Mar 2026, the weight rose most in Healthcare Services (+1.2 pts), and fell most in Pharmaceuticals & Biotechnology (−1.2 pts).
- Healthcare Services20.5% → 21.6%+1.2 pts
- Pharmaceuticals & Biotechnology75.3% → 74.1%−1.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Apr 2023 | Apr 2025 | Oct 2025 | Jan 2026 | Mar 2026 | Apr 2026 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 77.7% | 76.4% | 74.7% | 74.6% | 75.3% | 74.1% |
| Healthcare Services | 18.5% | 19.6% | 21.3% | 21.2% | 20.5% | 21.6% |
| Retailing | 2.1% | 3.6% | 3.3% | 3.7% | 3.9% | 3.8% |
| Pharmaceuticals | 1.4% | 0.5% | 0.6% | 0.5% | 0.4% | 0.5% |
Allocation in Apr 2026change vs Mar 2026
- Pharmaceuticals & Biotechnology (23)74.1%▼ 1.2 pts
- Healthcare Services (9)21.6%▲ 1.2 pts
- Retailing (1)3.8%
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Apr 2026
1.3%
▲ 0.8 pts vs Mar 2026
- Cash alone
- 1.3%
- cash and net receivables
- A year earlier
- 0.3%
- Apr 2025 · now ▲ 1.0 pts
- Last 12 months
- 0.3% – 2.6%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.